K-V Pharmaceutical operating income rises to $572,000 in February

By Jim Witters

Wilmington, Del., March 15 - K-V Pharmaceutical Co. posted operating income of $572,000 for February on $6.38 million in net revenue, according to the company's monthly operating report filed March 15 with the U.S. Bankruptcy Court for the Southern District of New York.

Those figures compare to $127,000 of operating income for January on $7.02 million of net revenue.

The net loss from continuing operations was $4.91 million in February, compared to $3.25 million in January.

The company also reported cash and cash equivalents of $34.25 million on Feb. 28, up from $33.54 million at the end of January.

K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4, 2012. The Chapter 11 case number is 12-13346.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.